Structure

Physi-Chem Properties

Molecular Weight:  578.16
Volume:  534.737
LogP:  -0.127
LogD:  0.269
LogS:  -4.451
# Rotatable Bonds:  7
TPSA:  217.97
# H-Bond Aceptor:  14
# H-Bond Donor:  7
# Rings:  5
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.176
Synthetic Accessibility Score:  4.531
Fsp3:  0.444
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.423
MDCK Permeability:  2.4968818252091296e-05
Pgp-inhibitor:  0.013
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.871
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.117
Plasma Protein Binding (PPB):  79.96940612792969%
Volume Distribution (VD):  0.639
Pgp-substrate:  11.657575607299805%

ADMET: Metabolism

CYP1A2-inhibitor:  0.063
CYP1A2-substrate:  0.111
CYP2C19-inhibitor:  0.079
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.009
CYP2C9-substrate:  0.104
CYP2D6-inhibitor:  0.196
CYP2D6-substrate:  0.262
CYP3A4-inhibitor:  0.033
CYP3A4-substrate:  0.015

ADMET: Excretion

Clearance (CL):  1.22
Half-life (T1/2):  0.519

ADMET: Toxicity

hERG Blockers:  0.531
Human Hepatotoxicity (H-HT):  0.097
Drug-inuced Liver Injury (DILI):  0.712
AMES Toxicity:  0.537
Rat Oral Acute Toxicity:  0.049
Maximum Recommended Daily Dose:  0.013
Skin Sensitization:  0.919
Carcinogencity:  0.496
Eye Corrosion:  0.003
Eye Irritation:  0.082
Respiratory Toxicity:  0.035

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC51314

Natural Product ID:  NPC51314
Common Name*:   DKUCORZJNCHLSI-BQLPCOOZSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  DKUCORZJNCHLSI-BQLPCOOZSA-N
Standard InCHI:  InChI=1S/C47H46O13/c1-28-26-35(56-41(50)31-18-10-6-11-19-31)38(58-43(52)33-22-14-8-15-23-33)46(27-54-29(2)48)40(59-44(53)34-24-16-9-17-25-34)37(57-42(51)32-20-12-7-13-21-32)36-39(55-30(3)49)47(28,46)60-45(36,4)5/h6-25,28,35-40H,26-27H2,1-5H3/t28-,35+,36-,37-,38+,39-,40-,46+,47-/m1/s1
SMILES:  CC(=O)OC[C@]12[C@@H](OC(=O)c3ccccc3)[C@@H](OC(=O)c3ccccc3)C[C@H]([C@@]32OC([C@H]([C@H]([C@H]1OC(=O)c1ccccc1)OC(=O)c1ccccc1)[C@H]3OC(=O)C)(C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL412596
PubChem CID:   44429329
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0002967] Hexacarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25272 Celastrus angulatus Species Celastraceae Eukaryota n.a. seed n.a. DOI[10.1016/S0031-9422(99)00216-2]
NPO25272 Celastrus angulatus Species Celastraceae Eukaryota seeds and root bark Henan, China n.a. PMID[26295746]
NPO25272 Celastrus angulatus Species Celastraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO25272 Celastrus angulatus Species Celastraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25272 Celastrus angulatus Species Celastraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO25272 Celastrus angulatus Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT519 Cell Line SH-SY5Y Homo sapiens Activity = 78.7 % PMID[493769]
NPT80 Cell Line Raji Homo sapiens Activity = 60.0 % PMID[493770]
NPT668 Individual Protein P-glycoprotein 1 Homo sapiens Ki = 1980.0 nM PMID[493768]
NPT35 Others n.a. LogP = 12.4 n.a. PMID[493768]
NPT668 Individual Protein P-glycoprotein 1 Homo sapiens Ki = 1995.26 nM PMID[493768]
NPT668 Individual Protein P-glycoprotein 1 Homo sapiens Imax = 29.3 % PMID[493768]
NPT2 Others Unspecified Activity = 39.8 % PMID[493770]
NPT2 Others Unspecified Activity = 11.5 % PMID[493770]
NPT2 Others Unspecified Activity = 81.3 % PMID[493770]
NPT2 Others Unspecified Activity = 100.0 % PMID[493770]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC51314 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC67777
0.9926 High Similarity NPC475429
0.9926 High Similarity NPC147217
0.9926 High Similarity NPC473673
0.9926 High Similarity NPC139067
0.9926 High Similarity NPC177340
0.9926 High Similarity NPC191082
0.9926 High Similarity NPC246480
0.9926 High Similarity NPC270498
0.9704 High Similarity NPC476094
0.9704 High Similarity NPC43241
0.9704 High Similarity NPC473085
0.9704 High Similarity NPC473758
0.9704 High Similarity NPC184747
0.9704 High Similarity NPC473112
0.9704 High Similarity NPC147880
0.9704 High Similarity NPC48017
0.9704 High Similarity NPC473613
0.9704 High Similarity NPC473109
0.9704 High Similarity NPC211137
0.9704 High Similarity NPC473060
0.9704 High Similarity NPC473081
0.9704 High Similarity NPC4341
0.9704 High Similarity NPC200592
0.964 High Similarity NPC281717
0.963 High Similarity NPC475652
0.963 High Similarity NPC214550
0.963 High Similarity NPC210591
0.9571 High Similarity NPC301556
0.9571 High Similarity NPC270590
0.9571 High Similarity NPC92293
0.9571 High Similarity NPC471101
0.9571 High Similarity NPC266265
0.9556 High Similarity NPC283375
0.9556 High Similarity NPC183122
0.9424 High Similarity NPC95265
0.9424 High Similarity NPC470231
0.9424 High Similarity NPC25768
0.9424 High Similarity NPC188865
0.9424 High Similarity NPC70716
0.9424 High Similarity NPC57628
0.9424 High Similarity NPC125106
0.9424 High Similarity NPC472573
0.9424 High Similarity NPC163719
0.9424 High Similarity NPC472569
0.9424 High Similarity NPC472570
0.9424 High Similarity NPC11685
0.9424 High Similarity NPC476974
0.9424 High Similarity NPC95810
0.9407 High Similarity NPC291638
0.9407 High Similarity NPC66761
0.9407 High Similarity NPC195647
0.9407 High Similarity NPC472577
0.9407 High Similarity NPC17877
0.9357 High Similarity NPC177940
0.9357 High Similarity NPC96903
0.9357 High Similarity NPC184817
0.9357 High Similarity NPC472568
0.9357 High Similarity NPC200471
0.9357 High Similarity NPC470157
0.9357 High Similarity NPC470159
0.9357 High Similarity NPC469349
0.9357 High Similarity NPC471104
0.9357 High Similarity NPC473088
0.9357 High Similarity NPC472575
0.9357 High Similarity NPC476973
0.9357 High Similarity NPC158663
0.9357 High Similarity NPC472571
0.9357 High Similarity NPC174982
0.9357 High Similarity NPC472572
0.9357 High Similarity NPC171525
0.9357 High Similarity NPC70403
0.9357 High Similarity NPC29704
0.9353 High Similarity NPC163087
0.9333 High Similarity NPC474608
0.9286 High Similarity NPC475122
0.9286 High Similarity NPC475759
0.9286 High Similarity NPC241951
0.9286 High Similarity NPC470152
0.9209 High Similarity NPC16912
0.9161 High Similarity NPC476975
0.9155 High Similarity NPC474935
0.9137 High Similarity NPC171207
0.9137 High Similarity NPC90614
0.9137 High Similarity NPC97667
0.9097 High Similarity NPC470245
0.9097 High Similarity NPC473214
0.9097 High Similarity NPC254558
0.9085 High Similarity NPC472556
0.9071 High Similarity NPC87448
0.9071 High Similarity NPC118080
0.9071 High Similarity NPC291599
0.9071 High Similarity NPC27377
0.9071 High Similarity NPC41481
0.9071 High Similarity NPC97947
0.9071 High Similarity NPC472576
0.9054 High Similarity NPC471102
0.9037 High Similarity NPC147561
0.9034 High Similarity NPC470153
0.9028 High Similarity NPC473215
0.9 High Similarity NPC275592
0.9 High Similarity NPC183270
0.9 High Similarity NPC100913
0.9 High Similarity NPC477904
0.8973 High Similarity NPC477905
0.8966 High Similarity NPC31829
0.8936 High Similarity NPC224491
0.8929 High Similarity NPC472371
0.8929 High Similarity NPC472395
0.8857 High Similarity NPC475373
0.8851 High Similarity NPC26033
0.8851 High Similarity NPC228204
0.8851 High Similarity NPC282239
0.8844 High Similarity NPC472548
0.8819 High Similarity NPC471107
0.8819 High Similarity NPC471100
0.8808 High Similarity NPC476077
0.8792 High Similarity NPC106895
0.8784 High Similarity NPC237549
0.8784 High Similarity NPC472022
0.8784 High Similarity NPC77719
0.8784 High Similarity NPC265395
0.8784 High Similarity NPC249471
0.8784 High Similarity NPC257213
0.8784 High Similarity NPC1173
0.8784 High Similarity NPC242262
0.8784 High Similarity NPC304876
0.8784 High Similarity NPC158333
0.8784 High Similarity NPC473414
0.8784 High Similarity NPC472005
0.8784 High Similarity NPC256142
0.8784 High Similarity NPC472030
0.8759 High Similarity NPC209592
0.8759 High Similarity NPC473602
0.8759 High Similarity NPC48599
0.8741 High Similarity NPC473111
0.8741 High Similarity NPC473110
0.8741 High Similarity NPC34012
0.8741 High Similarity NPC473082
0.8733 High Similarity NPC472393
0.8732 High Similarity NPC472547
0.8725 High Similarity NPC472549
0.8725 High Similarity NPC114410
0.8725 High Similarity NPC112523
0.8699 High Similarity NPC473760
0.8681 High Similarity NPC91703
0.8671 High Similarity NPC266374
0.8667 High Similarity NPC114927
0.8667 High Similarity NPC217091
0.8667 High Similarity NPC473083
0.8652 High Similarity NPC472551
0.8652 High Similarity NPC472545
0.8649 High Similarity NPC51602
0.8611 High Similarity NPC472546
0.8609 High Similarity NPC469771
0.8601 High Similarity NPC475400
0.86 High Similarity NPC34066
0.8592 High Similarity NPC39549
0.8582 High Similarity NPC473216
0.8582 High Similarity NPC473399
0.8581 High Similarity NPC7095
0.8581 High Similarity NPC112216
0.8581 High Similarity NPC469448
0.8571 High Similarity NPC472437
0.8552 High Similarity NPC477468
0.8552 High Similarity NPC477894
0.8523 High Similarity NPC471103
0.8514 High Similarity NPC76103
0.8514 High Similarity NPC60509
0.8514 High Similarity NPC250046
0.8514 High Similarity NPC81698
0.8511 High Similarity NPC48929
0.8506 High Similarity NPC472574
0.8503 High Similarity NPC240115
0.85 High Similarity NPC472394
0.85 High Similarity NPC238370
0.8497 Intermediate Similarity NPC477623
0.8493 Intermediate Similarity NPC34943
0.8493 Intermediate Similarity NPC38696
0.8477 Intermediate Similarity NPC473611
0.8477 Intermediate Similarity NPC469422
0.8462 Intermediate Similarity NPC30171
0.8456 Intermediate Similarity NPC165260
0.8456 Intermediate Similarity NPC161239
0.8456 Intermediate Similarity NPC198455
0.8444 Intermediate Similarity NPC70973
0.8435 Intermediate Similarity NPC125882
0.8435 Intermediate Similarity NPC127857
0.8431 Intermediate Similarity NPC469399
0.8429 Intermediate Similarity NPC472361
0.8425 Intermediate Similarity NPC131966
0.8425 Intermediate Similarity NPC191387
0.8421 Intermediate Similarity NPC323001
0.8421 Intermediate Similarity NPC326235
0.8411 Intermediate Similarity NPC472658
0.8411 Intermediate Similarity NPC472657
0.8406 Intermediate Similarity NPC473220
0.8406 Intermediate Similarity NPC470753
0.84 Intermediate Similarity NPC96308
0.8392 Intermediate Similarity NPC472374

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC51314 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7724 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD7236 Approved
0.759 Intermediate Similarity NPD7799 Discontinued
0.758 Intermediate Similarity NPD7239 Suspended
0.7545 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD7008 Discontinued
0.7399 Intermediate Similarity NPD8434 Phase 2
0.7384 Intermediate Similarity NPD8407 Phase 2
0.736 Intermediate Similarity NPD8485 Approved
0.7355 Intermediate Similarity NPD8166 Discontinued
0.7314 Intermediate Similarity NPD8360 Approved
0.7314 Intermediate Similarity NPD8435 Approved
0.7314 Intermediate Similarity NPD8361 Approved
0.731 Intermediate Similarity NPD8368 Discontinued
0.7299 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD8127 Discontinued
0.7244 Intermediate Similarity NPD7003 Approved
0.7241 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD8312 Approved
0.7225 Intermediate Similarity NPD8313 Approved
0.7216 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD7458 Discontinued
0.72 Intermediate Similarity NPD3764 Approved
0.72 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD7961 Discontinued
0.7152 Intermediate Similarity NPD7058 Phase 2
0.7152 Intermediate Similarity NPD7057 Phase 3
0.7135 Intermediate Similarity NPD5844 Phase 1
0.7125 Intermediate Similarity NPD6273 Approved
0.7103 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7102 Intermediate Similarity NPD8150 Discontinued
0.7081 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD7768 Phase 2
0.7047 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD8455 Phase 2
0.7029 Intermediate Similarity NPD2182 Approved
0.7025 Intermediate Similarity NPD4628 Phase 3
0.7024 Intermediate Similarity NPD5494 Approved
0.7014 Intermediate Similarity NPD7741 Discontinued
0.6972 Remote Similarity NPD5951 Approved
0.697 Remote Similarity NPD37 Approved
0.695 Remote Similarity NPD6858 Approved
0.695 Remote Similarity NPD7094 Approved
0.6946 Remote Similarity NPD4965 Approved
0.6946 Remote Similarity NPD4967 Phase 2
0.6946 Remote Similarity NPD4966 Approved
0.6946 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6939 Remote Similarity NPD6287 Discontinued
0.6928 Remote Similarity NPD7713 Phase 3
0.6928 Remote Similarity NPD7819 Suspended
0.6923 Remote Similarity NPD4198 Discontinued
0.6919 Remote Similarity NPD7473 Discontinued
0.6918 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6883 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6879 Remote Similarity NPD5406 Approved
0.6879 Remote Similarity NPD5404 Approved
0.6879 Remote Similarity NPD5408 Approved
0.6879 Remote Similarity NPD5405 Approved
0.6879 Remote Similarity NPD7228 Approved
0.6875 Remote Similarity NPD6190 Approved
0.6864 Remote Similarity NPD6234 Discontinued
0.686 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6857 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6853 Remote Similarity NPD2629 Approved
0.6852 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6845 Remote Similarity NPD7497 Discontinued
0.6842 Remote Similarity NPD6232 Discontinued
0.6815 Remote Similarity NPD7798 Approved
0.6815 Remote Similarity NPD3748 Approved
0.6815 Remote Similarity NPD1238 Approved
0.6803 Remote Similarity NPD5125 Phase 3
0.6803 Remote Similarity NPD5126 Approved
0.6788 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6786 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6784 Remote Similarity NPD6959 Discontinued
0.6772 Remote Similarity NPD2438 Suspended
0.675 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6748 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6747 Remote Similarity NPD6599 Discontinued
0.6739 Remote Similarity NPD164 Approved
0.6726 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6723 Remote Similarity NPD7240 Approved
0.6712 Remote Similarity NPD7610 Discontinued
0.671 Remote Similarity NPD8032 Phase 2
0.6708 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6707 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6707 Remote Similarity NPD7411 Suspended
0.6706 Remote Similarity NPD7075 Discontinued
0.6687 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6687 Remote Similarity NPD7390 Discontinued
0.6687 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6686 Remote Similarity NPD5402 Approved
0.6667 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7699 Phase 2
0.6667 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7700 Phase 2
0.6647 Remote Similarity NPD4380 Phase 2
0.6646 Remote Similarity NPD7097 Phase 1
0.6632 Remote Similarity NPD8320 Phase 1
0.6632 Remote Similarity NPD8319 Approved
0.6632 Remote Similarity NPD7870 Phase 2
0.6632 Remote Similarity NPD7871 Phase 2
0.6629 Remote Similarity NPD7685 Pre-registration
0.6629 Remote Similarity NPD6559 Discontinued
0.6627 Remote Similarity NPD5760 Phase 2
0.6627 Remote Similarity NPD5761 Phase 2
0.6625 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6623 Remote Similarity NPD6832 Phase 2
0.662 Remote Similarity NPD2067 Discontinued
0.6608 Remote Similarity NPD3749 Approved
0.6605 Remote Similarity NPD3750 Approved
0.6603 Remote Similarity NPD7715 Approved
0.6603 Remote Similarity NPD6663 Approved
0.6603 Remote Similarity NPD7714 Approved
0.6595 Remote Similarity NPD6534 Approved
0.6595 Remote Similarity NPD6535 Approved
0.659 Remote Similarity NPD7199 Phase 2
0.6588 Remote Similarity NPD3817 Phase 2
0.6587 Remote Similarity NPD3226 Approved
0.6579 Remote Similarity NPD7435 Discontinued
0.6571 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6571 Remote Similarity NPD6166 Phase 2
0.6571 Remote Similarity NPD7997 Clinical (unspecified phase)
0.6571 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6568 Remote Similarity NPD6801 Discontinued
0.6566 Remote Similarity NPD5403 Approved
0.6564 Remote Similarity NPD8462 Phase 1
0.6564 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6562 Remote Similarity NPD2935 Discontinued
0.6562 Remote Similarity NPD2796 Approved
0.6561 Remote Similarity NPD2979 Phase 3
0.6558 Remote Similarity NPD5736 Approved
0.6545 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6545 Remote Similarity NPD2533 Approved
0.6545 Remote Similarity NPD2534 Approved
0.6545 Remote Similarity NPD2532 Approved
0.6545 Remote Similarity NPD5401 Approved
0.6536 Remote Similarity NPD6764 Approved
0.6536 Remote Similarity NPD6765 Approved
0.6528 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6522 Remote Similarity NPD7266 Discontinued
0.6522 Remote Similarity NPD2346 Discontinued
0.6519 Remote Similarity NPD6355 Discontinued
0.6514 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6514 Remote Similarity NPD8051 Clinical (unspecified phase)
0.6507 Remote Similarity NPD690 Clinical (unspecified phase)
0.6497 Remote Similarity NPD7177 Discontinued
0.6497 Remote Similarity NPD6233 Phase 2
0.6495 Remote Similarity NPD8151 Discontinued
0.6492 Remote Similarity NPD7696 Phase 3
0.6492 Remote Similarity NPD7698 Approved
0.6492 Remote Similarity NPD7697 Approved
0.6485 Remote Similarity NPD6799 Approved
0.6471 Remote Similarity NPD5667 Approved
0.6462 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6462 Remote Similarity NPD7874 Approved
0.6461 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6457 Remote Similarity NPD7229 Phase 3
0.6456 Remote Similarity NPD4307 Phase 2
0.6455 Remote Similarity NPD8285 Discontinued
0.6447 Remote Similarity NPD3972 Approved
0.644 Remote Similarity NPD6823 Phase 2
0.6438 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6433 Remote Similarity NPD6798 Discontinued
0.6433 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6432 Remote Similarity NPD8404 Phase 2
0.6429 Remote Similarity NPD1930 Approved
0.6429 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6429 Remote Similarity NPD1929 Approved
0.6425 Remote Similarity NPD7074 Phase 3
0.6421 Remote Similarity NPD6780 Approved
0.6421 Remote Similarity NPD6779 Approved
0.6421 Remote Similarity NPD6776 Approved
0.6421 Remote Similarity NPD6781 Approved
0.6421 Remote Similarity NPD6777 Approved
0.6421 Remote Similarity NPD6778 Approved
0.6421 Remote Similarity NPD6782 Approved
0.6416 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6415 Remote Similarity NPD230 Phase 1
0.6412 Remote Similarity NPD6873 Phase 2
0.6412 Remote Similarity NPD6385 Approved
0.6412 Remote Similarity NPD6386 Approved
0.6404 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6404 Remote Similarity NPD3818 Discontinued
0.6402 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6402 Remote Similarity NPD4110 Phase 3
0.6398 Remote Similarity NPD2799 Discontinued
0.6395 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6393 Remote Similarity NPD6784 Approved
0.6393 Remote Similarity NPD6785 Approved
0.6383 Remote Similarity NPD5909 Discontinued
0.6382 Remote Similarity NPD1281 Approved
0.6379 Remote Similarity NPD919 Approved
0.6374 Remote Similarity NPD1934 Approved
0.6369 Remote Similarity NPD7095 Approved
0.6369 Remote Similarity NPD7054 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data